BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33083646)

  • 1. A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities.
    Gui C; Grimm J; Kleinberg LR; Zaki P; Spoleti N; Mukherjee D; Bettegowda C; Lim M; Redmond KJ
    Adv Radiat Oncol; 2020; 5(5):840-849. PubMed ID: 33083646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metastases resection cavity radio-surgery based on T2-weighted MRI: technique assessment.
    Teyateeti A; Brown PD; Mahajan A; Laack NN; Pollock BE
    J Neurooncol; 2020 May; 148(1):89-95. PubMed ID: 32303974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
    Redmond KJ; De Salles AAF; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan J; Suh J; Yomo S; Sahgal A
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):68-80. PubMed ID: 33891979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.
    Broemme J; Abu-Isa J; Kottke R; Beck J; Wiest R; Malthaner M; Schmidhalter D; Raabe A; Aebersold DM; Pica A
    Strahlenther Onkol; 2013 Sep; 189(9):765-70. PubMed ID: 23934329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
    Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
    Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
    Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
    J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrence patterns after postoperative stereotactic radiation surgery to resected brain metastases: A quantitative analysis to guide target delineation.
    Gui C; Moore J; Grimm J; Kleinberg L; McNutt T; Shen C; Chen L; Bettegowda C; Lim M; Redmond KJ
    Pract Radiat Oncol; 2018; 8(6):388-396. PubMed ID: 30029965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
    Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
    Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
    J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Control Probability After Radiosurgery of Brain Metastases With and Without Retreatment.
    Sharma M; Milano MT; Cummings M; Naqa IE
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):537-544. PubMed ID: 35863671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery.
    Vargo JA; Sparks KM; Singh R; Jacobson GM; Hack JD; Cifarelli CP
    J Neurooncol; 2018 Nov; 140(2):413-420. PubMed ID: 30094718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
    Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
    J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.